trending Market Intelligence /marketintelligence/en/news-insights/trending/9-tO0G3BEUkL-bQ9fv-LlA2 content esgSubNav
In This List

Insulet offers convertible senior notes to refinance existing debt

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Insulet offers convertible senior notes to refinance existing debt

Insulet Corp. said it plans to offer $660 million worth of convertible senior notes due 2026 in a private placement.

Acton, Mass.-based Insulet may also issue up to an additional $100 million worth of notes if there is an increase in demand for the securities.

The company plans to use the private offering to refinance its existing debt, including 1.25% convertible senior notes due 2021. The debt offering will be priced later.

Insulet develops, manufactures and sells insulin delivery systems for people with insulin-dependent diabetes.